New issues in assessing biotech sector: some empirical evidences and policy implications

A common view among many academics and policy makers is that biotech offer enormous opportunity for improving competitiveness and economic growth. For this reason there is a growing need to set upappropriate policy to improve the adoption and diffusion of biotech innovation. Neverthless, there are many interpretative problems about the identification of the biotech firm, due to the uncertainty about the border of the sector itself. The main objective of this paper is to provide a contribution to better define biotech industry considering the pervasive nature of innovation in this sector.